![Martin Ostrowski](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Martin Ostrowski
Directeur Technique/Scientifique/R&D chez Ryne Biotechnology, Inc.
Postes actifs de Martin Ostrowski
Sociétés | Poste | Début | Fin |
---|---|---|---|
Saisei Ventures LLC
![]() Saisei Ventures LLC Investment ManagersFinance Saisei Ventures LLC (Saisei Ventures) is a venture capital firm founded by Jonathan Yeh in 2020. The firm is headquartered in Cambridge, Massachusetts. | Private Equity Investor | 01/01/2023 | - |
Ryne Biotechnology, Inc.
![]() Ryne Biotechnology, Inc. BiotechnologyHealth Technology Ryne Biotechnology, Inc. is an American US-based biotechnology company that focuses on developing next-generation approaches to cure neurological disorders. The company utilizes induced pluripotent stem cell (iPSC) technology to advance its off-the-shelf neuron replacement therapeutics. Ryne Bio is dedicated to advancing a pipeline targeting neurological diseases by focusing on an iPSC technology platform and forging partnerships with leaders in surgical delivery and clinical development. | Directeur Technique/Scientifique/R&D | 01/03/2022 | - |
Historique de carrière de Martin Ostrowski
Anciens postes connus de Martin Ostrowski
Sociétés | Poste | Début | Fin |
---|---|---|---|
Dianomi Therapeutics, Inc.
![]() Dianomi Therapeutics, Inc. BiotechnologyHealth Technology Dianomi Therapeutics, Inc. engages in the development of Mineral Coated Microparticle (MCM) technology. It focuses on the improvement of drug molecules for targeting autoimmune diseases. The company was founded by Barry Kurokawa, William Murphy, Martin Ostrowski, and Anna Clements in 2017 and is headquartered in Madison, WI. | Directeur des opérations | 01/02/2019 | 31/07/2022 |
Fondateur | 01/02/2019 | 31/07/2020 | |
President | 01/08/2020 | 31/07/2022 | |
Vascugen, Inc.
![]() Vascugen, Inc. BiotechnologyHealth Technology Vascugen, Inc. provides biotechnology services. The company is headquartered in Madison, WI. | Directeur Technique/Scientifique/R&D | 01/06/2017 | 30/11/2019 |
Fondateur | 01/06/2017 | 30/11/2019 | |
mRNA RiboTherapeutics, Inc.
![]() mRNA RiboTherapeutics, Inc. BiotechnologyHealth Technology mRNA RiboTherapeutics, Inc. provides products and technology for making and using ribonucleic acid for translation in cells for clinical research and therapeutics. It offers products for MRNA production in vitro transcription, post-transcriptional capping, co--transcriptional capping, post-transcriptional tailing, modified NTP in vitro transcription, mRNA decapping, and RNase inhibition. The company is headquartered in Madison, WI. | Directeur/Membre du Conseil | 01/01/2011 | 02/01/2019 |
Formation de Martin Ostrowski
Case Western Reserve University School of Medicine | Graduate Degree |
Case Western Reserve University School of Law | Graduate Degree |
Statistiques
Internationale
Etats-Unis | 8 |
Opérationnelle
Founder | 2 |
Chief Tech/Sci/R&D Officer | 2 |
Graduate Degree | 2 |
Sectorielle
Health Technology | 5 |
Consumer Services | 3 |
Finance | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Entreprise privées | 5 |
---|---|
Dianomi Therapeutics, Inc.
![]() Dianomi Therapeutics, Inc. BiotechnologyHealth Technology Dianomi Therapeutics, Inc. engages in the development of Mineral Coated Microparticle (MCM) technology. It focuses on the improvement of drug molecules for targeting autoimmune diseases. The company was founded by Barry Kurokawa, William Murphy, Martin Ostrowski, and Anna Clements in 2017 and is headquartered in Madison, WI. | Health Technology |
Saisei Ventures LLC
![]() Saisei Ventures LLC Investment ManagersFinance Saisei Ventures LLC (Saisei Ventures) is a venture capital firm founded by Jonathan Yeh in 2020. The firm is headquartered in Cambridge, Massachusetts. | Finance |
Ryne Biotechnology, Inc.
![]() Ryne Biotechnology, Inc. BiotechnologyHealth Technology Ryne Biotechnology, Inc. is an American US-based biotechnology company that focuses on developing next-generation approaches to cure neurological disorders. The company utilizes induced pluripotent stem cell (iPSC) technology to advance its off-the-shelf neuron replacement therapeutics. Ryne Bio is dedicated to advancing a pipeline targeting neurological diseases by focusing on an iPSC technology platform and forging partnerships with leaders in surgical delivery and clinical development. | Health Technology |
Vascugen, Inc.
![]() Vascugen, Inc. BiotechnologyHealth Technology Vascugen, Inc. provides biotechnology services. The company is headquartered in Madison, WI. | Health Technology |
mRNA RiboTherapeutics, Inc.
![]() mRNA RiboTherapeutics, Inc. BiotechnologyHealth Technology mRNA RiboTherapeutics, Inc. provides products and technology for making and using ribonucleic acid for translation in cells for clinical research and therapeutics. It offers products for MRNA production in vitro transcription, post-transcriptional capping, co--transcriptional capping, post-transcriptional tailing, modified NTP in vitro transcription, mRNA decapping, and RNase inhibition. The company is headquartered in Madison, WI. | Health Technology |
- Bourse
- Insiders
- Martin Ostrowski
- Expérience